Latest Breaking News On - Immune programs profiled - Page 1 : comparemela.com

/PRNewswire/ Systimmune, Inc. (SystImmune) announced today that it will present clinical data from its lead programs at the ASCO Annual Meeting 2023 in.

United statesMartin olivoYi zhuSecurities exchangeSystimmune incWhile systimmune incPresentation detailsImmune programs profiledGrowth factor receptorsSecurities actSecurities exchange actPrivate securities litigation reform actInvestigational new drugSystimmune inc